Global Oral Cholera Vaccine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Oral Cholera Vaccine Market Research Report 2024
According to Mr Accuracy reports’s new survey, global Oral Cholera Vaccine market is projected to reach US$ 146.3 million in 2034, increasing from US$ 85 million in 2024, with the CAGR of 7.5% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Cholera Vaccine market research.
Global top four manufacturers of oral cholera vaccine include EuBiologics, Sanofi, United Biotech and Vabiotech, etc. The leading player is EuBiologics, who makes up over 40%.
South Korea is the largest producer, with a market share more than 80%, followed by India (10%). Mid East & Africa gains the segment, with a share about 30%.
Euvichol-Plus is the key segment among three types of oral cholera vaccine, accounting for over 40%. In terms of application, main uses of oral cholera vaccine are preventive campaigns and outbreak response.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Cholera Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
PaxVax
Sanofi
Valneva
EuBiologics
United Biotech
Vabiotech
PaxVax
Segment by Type
Euvichol-Plus
DUKORAL
Shanchol
Others
Preventive Campaigns
Outbreak Response
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Cholera Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Global top four manufacturers of oral cholera vaccine include EuBiologics, Sanofi, United Biotech and Vabiotech, etc. The leading player is EuBiologics, who makes up over 40%.
South Korea is the largest producer, with a market share more than 80%, followed by India (10%). Mid East & Africa gains the segment, with a share about 30%.
Euvichol-Plus is the key segment among three types of oral cholera vaccine, accounting for over 40%. In terms of application, main uses of oral cholera vaccine are preventive campaigns and outbreak response.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Cholera Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
PaxVax
Sanofi
Valneva
EuBiologics
United Biotech
Vabiotech
PaxVax
Segment by Type
Euvichol-Plus
DUKORAL
Shanchol
Others
Segment by Application
Preventive Campaigns
Outbreak Response
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Cholera Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source